Skip to main content

Analysts Offer Insights on Healthcare Companies: Co-Diagnostics (CODX), Stevanato Group (STVN) and Alpha Cognition Inc (ACOG)

Tipranks - Tue Nov 25, 2025

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Co-Diagnostics (CODXResearch Report), Stevanato Group (STVNResearch Report) and Alpha Cognition Inc (ACOGResearch Report).

TipRanks Black Friday Sale

Co-Diagnostics (CODX)

In a report released today, Yi Chen from H.C. Wainwright reiterated a Hold rating on Co-Diagnostics. The company’s shares closed last Friday at $0.35, close to its 52-week low of $0.28.

According to TipRanks.com, Chen is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -8.0% and a 39.2% success rate. Chen covers the Healthcare sector, focusing on stocks such as OKYO Pharma Limited Sponsored ADR, Orchestra BioMed Holdings, and Barinthus Biotherapeutics. ;'>

The the analyst consensus on Co-Diagnostics is currently a Hold rating.

See the top stocks recommended by analysts >>

Stevanato Group (STVN)

William Blair analyst Matt Larew maintained a Buy rating on Stevanato Group today. The company’s shares closed last Friday at $22.38.

According to TipRanks.com, Larew is a 1-star analyst with an average return of -3.5% and a 46.2% success rate. Larew covers the Healthcare sector, focusing on stocks such as Maravai Lifesciences Holdings, West Pharmaceutical Services, and Ginkgo Bioworks Holdings. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Stevanato Group with a $28.00 average price target.

Alpha Cognition Inc (ACOG)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Alpha Cognition Inc today and set a price target of $18.00. The company’s shares closed last Friday at $5.75.

According to TipRanks.com, Selvaraju is a 5-star analyst with an average return of 19.7% and a 53.9% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Santhera Pharmaceuticals Holding, Reviva Pharmaceuticals Holdings, and Aardvark Therapeutics, Inc. ;'>

Currently, the analyst consensus on Alpha Cognition Inc is a Moderate Buy with an average price target of $18.00.

Read More on CODX:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.